ID   MARK3_HUMAN             Reviewed;         776 AA.
AC   P27448; O60219; Q8TB41; Q8WX83; Q96RG1; Q9UMY9; Q9UN34;
DT   01-AUG-1992, integrated into UniProtKB/Swiss-Prot.
DT   15-DEC-2009, sequence version 3.
DT   05-OCT-2010, entry version 114.
DE   RecName: Full=MAP/microtubule affinity-regulating kinase 3;
DE            EC=2.7.11.1;
DE   AltName: Full=C-TAK1;
DE            Short=cTAK1;
DE   AltName: Full=Cdc25C-associated protein kinase 1;
DE   AltName: Full=ELKL motif kinase 2;
DE            Short=EMK-2;
DE   AltName: Full=Protein kinase STK10;
DE   AltName: Full=Ser/Thr protein kinase PAR-1;
DE   AltName: Full=Serine/threonine-protein kinase p78;
GN   Name=MARK3; Synonyms=CTAK1, EMK2;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 3), AND VARIANT GLY-466.
RX   MEDLINE=98202387; PubMed=9543386;
RA   Peng C.Y., Graves P.R., Ogg S., Thoma R.S., Byrnes M.J. III, Wu Z.,
RA   Stephenson M.T., Piwnica-Worms H.;
RT   "C-TAK1 protein kinase phosphorylates human Cdc25C on serine 216 and
RT   promotes 14-3-3 protein binding.";
RL   Cell Growth Differ. 9:197-208(1998).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 2), AND VARIANT GLY-466.
RA   Waggoner S.N., Stephen R., Farrar W.L., Howard O.M.Z.;
RT   "Human serine/threonine protein kinase cTAK1/Kp78/Mark3:
RT   Identification of a novel splice variant and a larger 5'UTR.";
RL   Submitted (JUN-1999) to the EMBL/GenBank/DDBJ databases.
RN   [3]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 4).
RX   MEDLINE=21326471; PubMed=11433294; DOI=10.1038/35083016;
RA   Sun T.-Q., Lu B., Feng J.-J., Reinhard C., Jan Y.N., Fantl W.J.,
RA   Williams L.T.;
RT   "PAR-1 is a Dishevelled-associated kinase and a positive regulator of
RT   Wnt signalling.";
RL   Nat. Cell Biol. 3:628-636(2001).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 5).
RA   Drewes G.;
RT   "Characterization of an alternatively spliced form of MARK3 from human
RT   brain.";
RL   Submitted (JAN-2002) to the EMBL/GenBank/DDBJ databases.
RN   [5]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 6).
RA   Maheshwari K.K., Som S., Parsa I.;
RL   Submitted (JAN-1992) to the EMBL/GenBank/DDBJ databases.
RN   [6]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   MEDLINE=22459283; PubMed=12508121; DOI=10.1038/nature01348;
RA   Heilig R., Eckenberg R., Petit J.-L., Fonknechten N., Da Silva C.,
RA   Cattolico L., Levy M., Barbe V., De Berardinis V., Ureta-Vidal A.,
RA   Pelletier E., Vico V., Anthouard V., Rowen L., Madan A., Qin S.,
RA   Sun H., Du H., Pepin K., Artiguenave F., Robert C., Cruaud C.,
RA   Bruels T., Jaillon O., Friedlander L., Samson G., Brottier P.,
RA   Cure S., Segurens B., Aniere F., Samain S., Crespeau H., Abbasi N.,
RA   Aiach N., Boscus D., Dickhoff R., Dors M., Dubois I., Friedman C.,
RA   Gouyvenoux M., James R., Madan A., Mairey-Estrada B., Mangenot S.,
RA   Martins N., Menard M., Oztas S., Ratcliffe A., Shaffer T., Trask B.,
RA   Vacherie B., Bellemere C., Belser C., Besnard-Gonnet M.,
RA   Bartol-Mavel D., Boutard M., Briez-Silla S., Combette S.,
RA   Dufosse-Laurent V., Ferron C., Lechaplais C., Louesse C., Muselet D.,
RA   Magdelenat G., Pateau E., Petit E., Sirvain-Trukniewicz P., Trybou A.,
RA   Vega-Czarny N., Bataille E., Bluet E., Bordelais I., Dubois M.,
RA   Dumont C., Guerin T., Haffray S., Hammadi R., Muanga J., Pellouin V.,
RA   Robert D., Wunderle E., Gauguet G., Roy A., Sainte-Marthe L.,
RA   Verdier J., Verdier-Discala C., Hillier L.W., Fulton L., McPherson J.,
RA   Matsuda F., Wilson R., Scarpelli C., Gyapay G., Wincker P., Saurin W.,
RA   Quetier F., Waterston R., Hood L., Weissenbach J.;
RT   "The DNA sequence and analysis of human chromosome 14.";
RL   Nature 421:601-607(2003).
RN   [7]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 3).
RC   TISSUE=Cervix;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [8]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 323-775 (ISOFORM 7).
RC   TISSUE=Urinary bladder;
RA   Reynolds C.H., Patel U.A., Anderton B.H.;
RT   "Homo sapiens mRNA partial sequence for a protein kinase, STK10,
RT   similar to p78/C-TAK1.";
RL   Submitted (JUL-1999) to the EMBL/GenBank/DDBJ databases.
RN   [9]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-234; SER-442; SER-492
RP   AND SER-624, AND MASS SPECTROMETRY.
RC   TISSUE=Leukemic T-cell;
RX   PubMed=17192257; DOI=10.1074/mcp.T600062-MCP200;
RA   Wissing J., Jaensch L., Nimtz M., Dieterich G., Hornberger R.,
RA   Keri G., Wehland J., Daub H.;
RT   "Proteomics analysis of protein kinases by target class-selective
RT   prefractionation and tandem mass spectrometry.";
RL   Mol. Cell. Proteomics 6:537-547(2007).
RN   [10]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-563; SER-566; THR-572
RP   AND THR-614, AND MASS SPECTROMETRY.
RC   TISSUE=Cervix carcinoma;
RX   PubMed=18220336; DOI=10.1021/pr0705441;
RA   Cantin G.T., Yi W., Lu B., Park S.K., Xu T., Lee J.-D.,
RA   Yates J.R. III;
RT   "Combining protein-based IMAC, peptide-based IMAC, and MudPIT for
RT   efficient phosphoproteomic analysis.";
RL   J. Proteome Res. 7:1346-1351(2008).
RN   [11]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-61; SER-403; SER-406;
RP   SER-423; SER-442; SER-478; SER-492; SER-499; THR-559; THR-572;
RP   SER-606; SER-610; SER-621 AND SER-666, AND MASS SPECTROMETRY.
RC   TISSUE=Cervix carcinoma;
RX   PubMed=18691976; DOI=10.1016/j.molcel.2008.07.007;
RA   Daub H., Olsen J.V., Bairlein M., Gnad F., Oppermann F.S., Korner R.,
RA   Greff Z., Keri G., Stemmann O., Mann M.;
RT   "Kinase-selective enrichment enables quantitative phosphoproteomics of
RT   the kinome across the cell cycle.";
RL   Mol. Cell 31:438-448(2008).
RN   [12]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-403; SER-492; SER-606
RP   AND SER-608, AND MASS SPECTROMETRY.
RC   TISSUE=Embryonic kidney;
RX   PubMed=19413330; DOI=10.1021/ac9004309;
RA   Gauci S., Helbig A.O., Slijper M., Krijgsveld J., Heck A.J.,
RA   Mohammed S.;
RT   "Lys-N and trypsin cover complementary parts of the phosphoproteome in
RT   a refined SCX-based approach.";
RL   Anal. Chem. 81:4493-4501(2009).
RN   [13]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-2; THR-3; SER-42;
RP   THR-61; THR-234; TYR-363; SER-364; SER-397; SER-399; SER-400; SER-401;
RP   SER-402; SER-403; SER-406; THR-420; SER-423; TYR-441; SER-442;
RP   SER-459; THR-461; SER-479; SER-492; SER-517; SER-522; SER-563;
RP   THR-564; SER-566; SER-568; SER-606; SER-608; SER-610; SER-621;
RP   SER-624; SER-662 AND SER-666, AND MASS SPECTROMETRY.
RX   PubMed=19369195; DOI=10.1074/mcp.M800588-MCP200;
RA   Oppermann F.S., Gnad F., Olsen J.V., Hornberger R., Greff Z., Keri G.,
RA   Mann M., Daub H.;
RT   "Large-scale proteomics analysis of the human kinome.";
RL   Mol. Cell. Proteomics 8:1751-1764(2009).
RN   [14]
RP   VARIANTS [LARGE SCALE ANALYSIS] ALA-452 AND GLY-466.
RX   PubMed=17344846; DOI=10.1038/nature05610;
RA   Greenman C., Stephens P., Smith R., Dalgliesh G.L., Hunter C.,
RA   Bignell G., Davies H., Teague J., Butler A., Stevens C., Edkins S.,
RA   O'Meara S., Vastrik I., Schmidt E.E., Avis T., Barthorpe S.,
RA   Bhamra G., Buck G., Choudhury B., Clements J., Cole J., Dicks E.,
RA   Forbes S., Gray K., Halliday K., Harrison R., Hills K., Hinton J.,
RA   Jenkinson A., Jones D., Menzies A., Mironenko T., Perry J., Raine K.,
RA   Richardson D., Shepherd R., Small A., Tofts C., Varian J., Webb T.,
RA   West S., Widaa S., Yates A., Cahill D.P., Louis D.N., Goldstraw P.,
RA   Nicholson A.G., Brasseur F., Looijenga L., Weber B.L., Chiew Y.-E.,
RA   DeFazio A., Greaves M.F., Green A.R., Campbell P., Birney E.,
RA   Easton D.F., Chenevix-Trench G., Tan M.-H., Khoo S.K., Teh B.T.,
RA   Yuen S.T., Leung S.Y., Wooster R., Futreal P.A., Stratton M.R.;
RT   "Patterns of somatic mutation in human cancer genomes.";
RL   Nature 446:153-158(2007).
CC   -!- FUNCTION: Involved in the specific phosphorylation of microtubule-
CC       associated proteins for tau, MAP2 and MAP4. Phosphorylates CDC25C
CC       on 'Ser-216'.
CC   -!- CATALYTIC ACTIVITY: ATP + a protein = ADP + a phosphoprotein.
CC   -!- INTERACTION:
CC       Q8WXK3:ASB13; NbExp=1; IntAct=EBI-707595, EBI-707573;
CC       Q15560:TCEA2; NbExp=1; IntAct=EBI-707595, EBI-710310;
CC       P31946:YWHAB; NbExp=1; IntAct=EBI-707595, EBI-359815;
CC       P61981:YWHAG; NbExp=1; IntAct=EBI-707595, EBI-359832;
CC       P27348:YWHAQ; NbExp=1; IntAct=EBI-707595, EBI-359854;
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=7;
CC       Name=1;
CC         IsoId=P27448-1; Sequence=Displayed;
CC       Name=2; Synonyms=CTAK75a;
CC         IsoId=P27448-2; Sequence=VSP_004944;
CC       Name=3;
CC         IsoId=P27448-3; Sequence=VSP_004942, VSP_004944;
CC       Name=4;
CC         IsoId=P27448-4; Sequence=VSP_004942, VSP_004945;
CC       Name=5;
CC         IsoId=P27448-5; Sequence=VSP_004942;
CC       Name=6; Synonyms=p58;
CC         IsoId=P27448-6; Sequence=VSP_004942, VSP_004943, VSP_004944;
CC       Name=7;
CC         IsoId=P27448-7; Sequence=VSP_004943;
CC   -!- TISSUE SPECIFICITY: Ubiquitous.
CC   -!- SIMILARITY: Belongs to the protein kinase superfamily. CAMK
CC       Ser/Thr protein kinase family. MARK subfamily.
CC   -!- SIMILARITY: Contains 1 KA1 (kinase-associated) domain.
CC   -!- SIMILARITY: Contains 1 protein kinase domain.
CC   -!- SIMILARITY: Contains 1 UBA domain.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; U64205; AAC15093.1; -; mRNA.
DR   EMBL; AF159295; AAD48007.1; -; mRNA.
DR   EMBL; AF387637; AAK82367.1; -; mRNA.
DR   EMBL; AF465413; AAL69982.1; -; mRNA.
DR   EMBL; M80359; AAA59991.1; -; mRNA.
DR   EMBL; AL133367; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; BC024773; AAH24773.1; -; mRNA.
DR   EMBL; AF170723; AAD51631.1; -; mRNA.
DR   IPI; IPI00183118; -.
DR   IPI; IPI00220505; -.
DR   IPI; IPI00220506; -.
DR   IPI; IPI00220507; -.
DR   IPI; IPI00220508; -.
DR   IPI; IPI00220509; -.
DR   IPI; IPI00220510; -.
DR   PIR; S27966; S27966.
DR   RefSeq; NP_001122390.1; -.
DR   RefSeq; NP_001122391.1; -.
DR   RefSeq; NP_001122392.1; -.
DR   RefSeq; NP_001122393.1; -.
DR   RefSeq; NP_002367.4; -.
DR   UniGene; Hs.35828; -.
DR   PDB; 2QNJ; X-ray; 2.70 A; A/B=48-393.
DR   PDB; 3FE3; X-ray; 1.90 A; A/B=41-390.
DR   PDBsum; 2QNJ; -.
DR   PDBsum; 3FE3; -.
DR   ProteinModelPortal; P27448; -.
DR   SMR; P27448; 680-776.
DR   DIP; DIP-34637N; -.
DR   IntAct; P27448; 43.
DR   MINT; MINT-272697; -.
DR   STRING; P27448; -.
DR   PhosphoSite; P27448; -.
DR   PRIDE; P27448; -.
DR   Ensembl; ENST00000335102; ENSP00000335347; ENSG00000075413.
DR   GeneID; 4140; -.
DR   KEGG; hsa:4140; -.
DR   UCSC; uc001ymw.2; human.
DR   UCSC; uc001ymx.2; human.
DR   UCSC; uc001yna.2; human.
DR   UCSC; uc010awp.1; human.
DR   CTD; 4140; -.
DR   GeneCards; GC14P103851; -.
DR   HGNC; HGNC:6897; MARK3.
DR   HPA; HPA024652; -.
DR   MIM; 602678; gene.
DR   PharmGKB; PA30640; -.
DR   eggNOG; prNOG08718; -.
DR   HOVERGEN; HBG052453; -.
DR   InParanoid; P27448; -.
DR   OMA; STIPDQR; -.
DR   PhylomeDB; P27448; -.
DR   BRENDA; 2.7.11.1; 247.
DR   ArrayExpress; P27448; -.
DR   Bgee; P27448; -.
DR   CleanEx; HS_MARK3; -.
DR   Genevestigator; P27448; -.
DR   GermOnline; ENSG00000075413; Homo sapiens.
DR   GO; GO:0005524; F:ATP binding; IEA:UniProtKB-KW.
DR   GO; GO:0005515; F:protein binding; IPI:IntAct.
DR   GO; GO:0004674; F:protein serine/threonine kinase activity; IEA:UniProtKB-KW.
DR   GO; GO:0006468; P:protein amino acid phosphorylation; IEA:InterPro.
DR   InterPro; IPR020636; Ca/CaM-dep_prot_kinase-like.
DR   InterPro; IPR001772; Kinase-assoc_KA1.
DR   InterPro; IPR011009; Kinase-like_dom.
DR   InterPro; IPR020669; MAP/microtub-affinity-reg_kin3.
DR   InterPro; IPR000719; Prot_kinase_cat_dom.
DR   InterPro; IPR017441; Protein_kinase_ATP_BS.
DR   InterPro; IPR017442; Se/Thr_prot_kinase-like_dom.
DR   InterPro; IPR008271; Ser/Thr_prot_kinase_AS.
DR   InterPro; IPR002290; Ser/Thr_prot_kinase_dom.
DR   InterPro; IPR015940; UBA/transl_elong_EF1B_N_euk.
DR   PANTHER; PTHR22982; Ca/CaM-dep_prot_kinase-like; 1.
DR   PANTHER; PTHR22982:SF54; MAP/microtub-affinity-reg_kin3; 1.
DR   Pfam; PF02149; KA1; 1.
DR   Pfam; PF00069; Pkinase; 1.
DR   SMART; SM00220; S_TKc; 1.
DR   SMART; SM00165; UBA; 1.
DR   SUPFAM; SSF56112; Kinase_like; 1.
DR   PROSITE; PS50032; KA1; 1.
DR   PROSITE; PS00107; PROTEIN_KINASE_ATP; 1.
DR   PROSITE; PS50011; PROTEIN_KINASE_DOM; 1.
DR   PROSITE; PS00108; PROTEIN_KINASE_ST; 1.
DR   PROSITE; PS50030; UBA; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Alternative splicing; ATP-binding; Complete proteome;
KW   Kinase; Nucleotide-binding; Phosphoprotein; Polymorphism;
KW   Serine/threonine-protein kinase; Transferase.
FT   CHAIN         1    776       MAP/microtubule affinity-regulating
FT                                kinase 3.
FT                                /FTId=PRO_0000086304.
FT   DOMAIN       56    330       Protein kinase.
FT   DOMAIN      326    365       UBA.
FT   DOMAIN      727    776       KA1.
FT   NP_BIND      62     70       ATP (By similarity).
FT   ACT_SITE    201    201       Proton acceptor (By similarity).
FT   BINDING      85     85       ATP (By similarity).
FT   MOD_RES       2      2       Phosphoserine.
FT   MOD_RES       3      3       Phosphothreonine.
FT   MOD_RES      42     42       Phosphoserine.
FT   MOD_RES      61     61       Phosphothreonine.
FT   MOD_RES     234    234       Phosphothreonine.
FT   MOD_RES     363    363       Phosphotyrosine.
FT   MOD_RES     364    364       Phosphoserine.
FT   MOD_RES     397    397       Phosphoserine.
FT   MOD_RES     399    399       Phosphoserine.
FT   MOD_RES     400    400       Phosphoserine.
FT   MOD_RES     401    401       Phosphoserine.
FT   MOD_RES     402    402       Phosphoserine.
FT   MOD_RES     403    403       Phosphoserine.
FT   MOD_RES     406    406       Phosphoserine.
FT   MOD_RES     420    420       Phosphothreonine.
FT   MOD_RES     423    423       Phosphoserine.
FT   MOD_RES     441    441       Phosphotyrosine.
FT   MOD_RES     442    442       Phosphoserine.
FT   MOD_RES     459    459       Phosphoserine.
FT   MOD_RES     461    461       Phosphothreonine.
FT   MOD_RES     478    478       Phosphoserine.
FT   MOD_RES     479    479       Phosphoserine.
FT   MOD_RES     492    492       Phosphoserine.
FT   MOD_RES     499    499       Phosphoserine.
FT   MOD_RES     517    517       Phosphoserine.
FT   MOD_RES     522    522       Phosphoserine.
FT   MOD_RES     559    559       Phosphothreonine.
FT   MOD_RES     563    563       Phosphoserine.
FT   MOD_RES     564    564       Phosphothreonine.
FT   MOD_RES     566    566       Phosphoserine.
FT   MOD_RES     568    568       Phosphoserine.
FT   MOD_RES     572    572       Phosphothreonine.
FT   MOD_RES     606    606       Phosphoserine.
FT   MOD_RES     608    608       Phosphoserine.
FT   MOD_RES     610    610       Phosphoserine.
FT   MOD_RES     614    614       Phosphothreonine.
FT   MOD_RES     621    621       Phosphoserine.
FT   MOD_RES     624    624       Phosphoserine.
FT   MOD_RES     662    662       Phosphoserine.
FT   MOD_RES     666    666       Phosphoserine.
FT   VAR_SEQ     162    184       Missing (in isoform 3, isoform 4, isoform
FT                                5 and isoform 6).
FT                                /FTId=VSP_004942.
FT   VAR_SEQ     394    409       Missing (in isoform 6 and isoform 7).
FT                                /FTId=VSP_004943.
FT   VAR_SEQ     638    661       Missing (in isoform 2, isoform 3 and
FT                                isoform 6).
FT                                /FTId=VSP_004944.
FT   VAR_SEQ     638    646       Missing (in isoform 4).
FT                                /FTId=VSP_004945.
FT   VARIANT     452    452       V -> A.
FT                                /FTId=VAR_040765.
FT   VARIANT     466    466       S -> G (in dbSNP:rs56305318).
FT                                /FTId=VAR_046763.
FT   CONFLICT    125    125       E -> Q (in Ref. 5; AAA59991).
FT   CONFLICT    139    139       E -> K (in Ref. 4; AAL69982 and 5;
FT                                AAA59991).
FT   CONFLICT    149    149       R -> K (in Ref. 2; AAD48007).
FT   CONFLICT    433    433       F -> S (in Ref. 1; AAC15093, 2; AAD48007,
FT                                3; AAK82367, 4; AAL69982, 5; AAA59991, 7;
FT                                AAH24773 and 8; AAD51631).
FT   CONFLICT    448    448       A -> G (in Ref. 5; AAA59991).
FT   CONFLICT    479    479       S -> T (in Ref. 5; AAA59991).
FT   CONFLICT    539    539       A -> D (in Ref. 5; AAA59991).
FT   CONFLICT    626    626       N -> T (in Ref. 5; AAA59991).
FT   CONFLICT    668    668       E -> K (in Ref. 5; AAA59991).
FT   STRAND       56     61
FT   STRAND       68     76
FT   STRAND       81     88
FT   HELIX        89     91
FT   HELIX        94    109
FT   STRAND      118    123
FT   STRAND      125    132
FT   HELIX       140    146
FT   HELIX       152    161
FT   HELIX       185    194
FT   HELIX       204    206
FT   STRAND      207    209
FT   STRAND      215    217
FT   HELIX       224    226
FT   TURN        232    235
FT   HELIX       239    241
FT   HELIX       244    247
FT   HELIX       256    261
FT   HELIX       265    271
FT   HELIX       281    289
FT   HELIX       301    310
FT   TURN        315    317
FT   HELIX       321    324
FT   TURN        328    331
FT   HELIX       352    358
FT   HELIX       365    373
FT   HELIX       379    386
SQ   SEQUENCE   776 AA;  87005 MW;  1BEB7924B32AF600 CRC64;
     MSTRTPLPTV NERDTENHTS HGDGRQEVTS RTSRSGARCR NSIASCADEQ PHIGNYRLLK
     TIGKGNFAKV KLARHILTGR EVAIKIIDKT QLNPTSLQKL FREVRIMKIL NHPNIVKLFE
     VIETEKTLYL IMEYASGGEV FDYLVAHGRM KEKEARSKFR QGCQAGQTIK VQVSFDLLSL
     MFTFIVSAVQ YCHQKRIVHR DLKAENLLLD ADMNIKIADF GFSNEFTVGG KLDTFCGSPP
     YAAPELFQGK KYDGPEVDVW SLGVILYTLV SGSLPFDGQN LKELRERVLR GKYRIPFYMS
     TDCENLLKRF LVLNPIKRGT LEQIMKDRWI NAGHEEDELK PFVEPELDIS DQKRIDIMVG
     MGYSQEEIQE SLSKMKYDEI TATYLLLGRK SSELDASDSS SSSNLSLAKV RPSSDLNNST
     GQSPHHKVQR SVFSSQKQRR YSDHAGPAIP SVVAYPKRSQ TSTADSDLKE DGISSRKSSG
     SAVGGKGIAP ASPMLGNASN PNKADIPERK KSSTVPSSNT ASGGMTRRNT YVCSERTTAD
     RHSVIQNGKE NSTIPDQRTP VASTHSISSA ATPDRIRFPR GTASRSTFHG QPRERRTATY
     NGPPASPSLS HEATPLSQTR SRGSTNLFSK LTSKLTRRNM SFRFIKRLPT EYERNGRYEG
     SSRNVSAEQK DENKEAKPRS LRFTWSMKTT SSMDPGDMMR EIRKVLDANN CDYEQRERFL
     LFCVHGDGHA ENLVQWEMEV CKLPRLSLNG VRFKRISGTS IAFKNIASKI ANELKL
//
